Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Marfella

Showing results (251-260 of 306) with videos related to

Pageof 31
Sort By:
European Journal of Internal Medicine|April 16, 2023
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulationCelestino Sardu, Gianluca Gatta, Gorizio Pieretti, et al.
Biomedicines|August 27, 2021
Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial InfarctionCelestino Sardu, Nunzia D'Onofrio, Michele Torella, et al.
Diabetes/Metabolism Research and Reviews|May 5, 2025
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients?Celestino Sardu, Nunzia D'Onofrio, Maria Consiglia Trotta, et al.
Journal of the American College of Cardiology|June 20, 2006
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatmentRaffaele Marfella, Michele D'Amico, Clara Di Filippo, et al.
Journal of Cardiology|September 9, 2015
Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathyRaffaele Marfella, Michelangela Barbieri, Celestino Sardu, et al.
JCI Insight|March 29, 2019
Prior β-blocker treatment decreases leukocyte responsiveness to injuryLaurel A Grisanti, Claudio de Lucia, Toby P Thomas, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2025
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN StudyAlfredo Caturano, Raffaele Galiero, Vittorio Simeon, et al.
Pharmacological Research|June 13, 2022
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical besideCelestino Sardu, Massimo Massetti, Lucia Scisciola, et al.
JACC. Advances|August 14, 2024
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac AmyloidosisCarlo Fumagalli, Mathew S Maurer, Marianna Fontana, et al.
Frontiers in Physiology|September 25, 2018
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics PatientsCelestino Sardu, Gorizio Pieretti, Nunzia D'Onofrio, et al.
Pageof 31

Showing results (251-260 of 306) with videos related to

Sort By:
Pageof 31
European Journal of Internal Medicine|April 16, 2023
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulationCelestino Sardu, Gianluca Gatta, Gorizio Pieretti, et al.
Biomedicines|August 27, 2021
Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial InfarctionCelestino Sardu, Nunzia D'Onofrio, Michele Torella, et al.
Diabetes/Metabolism Research and Reviews|May 5, 2025
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients?Celestino Sardu, Nunzia D'Onofrio, Maria Consiglia Trotta, et al.
Journal of the American College of Cardiology|June 20, 2006
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatmentRaffaele Marfella, Michele D'Amico, Clara Di Filippo, et al.
Journal of Cardiology|September 9, 2015
Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathyRaffaele Marfella, Michelangela Barbieri, Celestino Sardu, et al.
JCI Insight|March 29, 2019
Prior β-blocker treatment decreases leukocyte responsiveness to injuryLaurel A Grisanti, Claudio de Lucia, Toby P Thomas, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2025
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN StudyAlfredo Caturano, Raffaele Galiero, Vittorio Simeon, et al.
Pharmacological Research|June 13, 2022
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical besideCelestino Sardu, Massimo Massetti, Lucia Scisciola, et al.
JACC. Advances|August 14, 2024
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac AmyloidosisCarlo Fumagalli, Mathew S Maurer, Marianna Fontana, et al.
Frontiers in Physiology|September 25, 2018
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics PatientsCelestino Sardu, Gorizio Pieretti, Nunzia D'Onofrio, et al.
Pageof 31